ADAMTS13 and preeclampsia: Mild to moderate deficiency of ADAMTS13 activity or increased ratios of VWF to ADAMTS13 have been shown to be risk factors for the development of systemic inflammation, myocardial or cerebral infarction, preeclampsia or eclampsia, and cerebral malaria[8–11].